Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IVVD stock hub

Invivyd, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IVVDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

424.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IVVD

In the news

Latest news · IVVD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-34

P25 -106.6P50 -46.9P75 -3.1

ROIC-22.2

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IVVD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001832038
Company name	Invivyd, Inc.
Country	United States
Country code	US
Cusip	00534A102
Employees	122
Employees Change	22%
Employees Change Percent	22
Enterprise value	$200M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-08-06
Isin	US00534A1025
Last refreshed	2026-05-10
Market cap	$424.2M
Market cap category	Small-Cap
Price	$1.5
Price currency	USD
Rev Per Employee	437,918.03x
Sector	Healthcare
Sic	2836
Symbol	IVVD
Website	https://www.invivyd.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.37%
EV Sales Forward	2.49x
EV/Sales	3.74x
FCF yield	-13.74%
P/B ratio	1.75x
P/S ratio	7.94x
PS Forward	5.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-103.99%
EBITDA Margin	-102.58%
Gross margin	92.99%
Gross Profit	$49.7M
Gross Profit Growth	109.03%
Gross Profit Growth Q	22.69%
Net Income	$-52.5M
Net Income Growth Quarters	5%
Net Income Growth Years	3%
Pretax Margin	-98.25%
Profit Margin	-98.25%
Profit Per Employee	$-430,238
ROA	-17.09
Roa5y	-37.3
ROCE	-22.89
ROE	-33.96
Roe5y	-73.69
ROIC	-22.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	156.49%
Cagr3y	8.02%
EPS Growth Years	4
Revenue Growth	110.47x
Revenue Growth Q	24.51x
Revenue Growth Quarters	3x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.26
Assets	$276.9M
Cash	$226.7M
Current Assets	$247.5M
Current Liabilities	$34.2M
Debt	$2.5M
Debt Equity	$0.01
Equity	$241.5M
Liabilities	$35.3M
Long Term Assets	$29.4M
Long Term Liabilities	$1.2M
Net Cash	$224.2M
Net Cash By Market Cap	$52.85
Net Cash Growth	229.48%
Net Debt Equity	$-0.93
Tangible Book Value	$241.5M
Tangible Book Value Per Share	$0.86
WACC	8.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.24
Net Working Capital	$-12.1M
Quick ratio	7.06
Working Capital	$213.3M
Working Capital Turnover	$0.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-45.26%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	156.32%
200-day SMA	1.66
3Y total return	26.05%
50-day SMA	1.55
50-day SMA vs 200-day SMA	50under200
All Time High	78.82
All Time High Change	-98.1%
All Time High Date	2021-11-30
All Time Low	0.35
All Time Low Change	323.01%
All Time Low Date	2025-01-30
ATR	0.12
Beta	0.71
Beta1y	1.26
Beta2y	1.58
Ch YTD	-39.27
High	1.53
High52	3.07
High52 Date	2025-11-17
High52ch	-51.14%
Low	1.43
Low52	0.48
Low52 Date	2025-08-21
Low52ch	210.56%
Ma50ch	-3.47%
Premarket Change Percent	0.7
Premarket Price	$1.44
Premarket Volume	10,092
Price vs 200-day SMA	-9.37%
RSI	49.66
RSI Monthly	42.68
RSI Weekly	45.52
Sharpe ratio	1.24x
Sortino ratio	2.7
Total Return	-45.26%
Tr YTD	-39.27
Tr1m	16.28%
Tr1w	-1.32%
Tr3m	-5.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	3
Analyst Price Target Top	$8.33
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.08
Earnings Revenue Estimate	18,120,000x
Earnings Revenue Estimate Growth	60.3x
Operating Income	$-55.6M
Operating margin	-104
Price target	$8.75
Price Target Change	$483
Price Target Change Top	$455

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	167,800,608%
Float Percent	59.33%
Shares Insiders	0.24%
Shares Institutions	58.34%
Shares Out	282,803,863
Shares Qo Q	63.5%
Shares Yo Y	45.26%
Short Float	17.44%
Short Ratio	7.11
Short Shares	10.35

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-69.9M
Average Volume	1,718,932.3x
Bv Per Share	0.86
CAPEX	$-155,000
Ch1m	16.28
Ch1w	-1.32
Ch1y	156.3
Ch3m	-5.66
Ch3y	26.05
Ch6m	-5.36
Change	4.9%
Change From Open	4.9
Close	1.43
Days Gap	0
Depreciation Amortization	755,000
Dollar Volume	2,201,622
Earnings Date	2026-05-14
Earnings Time	bmo
EBIT	$-55.6M
EBITDA	$-54.8M
EPS	$-0.3
F Score	2
FCF	$-58.3M
FCF EV Yield	-29.14x
FCF Per Share	$-0.21
Financing CF	215,630,000
Fiscal Year End	December
Founded	2,020
Investing CF	-155,000
Ipr	-91.18
Iprfo	-92.86
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-05
Ma150	1.89
Ma150ch	-20.63%
Ma20	1.54
Ma20ch	-2.28%
Net CF	157,340,000
Next Earnings Date	2026-05-14
Open	1.43
Optionable	Yes
Position In Range	70
Ppne	3,807,000
Pre Close	1.43
Price Date	2026-05-08
Ptbv Ratio	1.76
Relative Volume	0.85x
Revenue	53,426,000x
SBC By Revenue	21.79x
Share Based Comp	11,643,000
Tr6m	-5.36%
Us State	Connecticut
Volume	1,467,748
Z Score	-0.7

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IVVD pay a dividend?

Capital-return profile for this ticker.

Performance

IVVD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IVVD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+58.3%

Float: +59.3% of shares outstanding

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IVVD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.7

Neutral momentum band

Price vs 200-day MA

-9.4%

50/200-day relationship not available

Beta (5Y)

0.71

Less volatile than the market

Sharpe ratio

1.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IVVD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IVVD stock rating?

Invivyd, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IVVD analysis?

The full report lives at /stocks/IVVD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IVVD?

The latest report frames IVVD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IVVD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.